ScoreWhy is Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 12.32%
- The company has been able to generate a Return on Capital Employed (avg) of 12.32% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 5.61% and Operating profit at -6.41% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 13.83% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 5.61% and Operating profit at -6.41% over the last 5 years
4
Negative results in Jun 26
- INTEREST(HY) At CNY 31.88 MM has Grown at 29.24%
- PRE-TAX PROFIT(Q) At CNY 88.84 MM has Fallen at -44.13%
- RAW MATERIAL COST(Y) Grown by 12.47% (YoY)
5
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 3.23% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -25.66% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
-25.66%
-1.23
30.56%
China Shanghai Composite
3.23%
0.22
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.61%
EBIT Growth (5y)
-6.41%
EBIT to Interest (avg)
9.75
Debt to EBITDA (avg)
0.53
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.44
Tax Ratio
16.83%
Dividend Payout Ratio
27.78%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.34%
ROE (avg)
13.83%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
1.58
EV to EBIT
14.24
EV to EBITDA
11.34
EV to Capital Employed
1.65
EV to Sales
2.55
PEG Ratio
NA
Dividend Yield
1.46%
ROCE (Latest)
11.60%
ROE (Latest)
7.56%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 0.79 times
CASH AND EQV(HY)
Highest at CNY 6,825.56 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -12.5 %
-18What is not working for the Company
INTEREST(HY)
At CNY 31.88 MM has Grown at 29.24%
PRE-TAX PROFIT(Q)
At CNY 88.84 MM has Fallen at -44.13%
RAW MATERIAL COST(Y)
Grown by 12.47% (YoY
OPERATING PROFIT MARGIN(Q)
Lowest at 16.12 %
NET PROFIT(Q)
At CNY 95.14 MM has Fallen at -27.99%
Here's what is working for Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Inventory Turnover Ratio
Highest at 0.79 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Cash and Eqv
Highest at CNY 6,825.56 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -12.5 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Interest
At CNY 31.88 MM has Grown at 29.24%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Pre-Tax Profit
At CNY 88.84 MM has Fallen at -44.13%
over average net sales of the previous four periods of CNY 159.02 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Operating Profit Margin
Lowest at 16.12 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Net Profit
At CNY 95.14 MM has Fallen at -27.99%
over average net sales of the previous four periods of CNY 132.12 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Raw Material Cost
Grown by 12.47% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
